Floatz logo

Bifidobacterium Bifidum

Probiotics

National Institute of Pediatrics, MexicoPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Probiotics cohort.

Asset / SponsorPhaseRating
Lactobacillus Rhamnosus
National Institute of Pediatrics, Mexico
Phase 2CCC
HUMAN FAECAL MATTER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2CCC

Same molecule, other indications

Bifidobacterium Bifidum is also rated in:

Non-small Cell Lung Cancer Stage IIDormant
CCC
Indicative ·
53 / 100
View asset →
precursor lymphoblastic lymphoma/leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →